menu
    • menu

    Company profile for Osel Pharma

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Our proprietary approach identifies differences between healthy and disease-r...
    Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Our proprietary approach identifies differences between healthy and disease-related microbiomes, and leverages beneficial microbes to treat problematic disruptions or ‘dysbioses’.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Osel PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    320 Logue Ave Mountain View, CA 94043
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oselinc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Osel Enters Agreement with SWOG Cancer Research Network
    Osel Enters Agreement with SWOG Cancer Research Network

    08 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-08/osel-enters-agreement-with-swog-cancer-research-network-for-first-ever-pivotal-trial-of-a-microbiome

    PHARMIWEB
    08 Jan 2026
    Share Share
    City of Hope, Osel Announce Live Biotherapeutic Product CBM588's Efficacy
    City of Hope, Osel Announce Live Biotherapeutic Product CBM588's Efficacy

    28 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220228005065/en

    BUSINESSWIRE
    28 Feb 2022
    Share Share
    Osel Obtains Exclusive License from Danish Research Consortia for IP Related
    Osel Obtains Exclusive License from Danish Research Consortia for IP Related

    03 Feb 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210203005177/en

    BUSINESSWIRE
    03 Feb 2021
    Share Share
    Osel Obtains Exclusive License from Danish Research Consortia for IP Related
    Osel Obtains Exclusive License from Danish Research Consortia for IP Related

    03 Feb 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/osel-obtains-exclusive-license-from-danish-research-consortia-for-ip-related-to-osel-s-lactin-v-in-women-undergoing-in-vitro-fertilization/#:~:text=)%20News%20(894)-,Osel%20Obtains%20Exclusive%20License%20from%20Danish%20Research%20Consortia%20for%20IP,Women%20Undergoing%20In%2DVitro%20Fertilization&text=%E2%80%9CLACTIN%2DV%2C%20which%20contains,healthier%20vaginal%20microbiome%20for%20IVF.%E2%80%9D

    BIOSPACE
    03 Feb 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search